70
Participants
Start Date
December 1, 2024
Primary Completion Date
March 31, 2025
Study Completion Date
May 31, 2025
0.1% xylometazoline nasal drops
Xylometazoline is direct acting, non selective, adrenergic agonist binding with alpha 1\&2 receptors, used for vasoconstriction to decrease nasal bleeding.
Adrenaline nasal pack
Adrenaline is direct acting, non selective, adrenergic agonist binding with alpha and beta receptors both, used for vasoconstriction to decrease nasal bleeding.
RECRUITING
Shaheed Mohtarma Benazir Bhutto Institute of Trauma, Karachi
Shaheed Mohtarma Benazir Bhutto Institue of Trauma
OTHER